Our individual journeys to discover new therapies that improve human health may be unique, but we share a common challenge: bridging the gap between discovery and patient impact. Moving a promising target from the bench through the translational pipeline demands new skills, new partners, and new ways of thinking — and the distance between a validated hit and a viable therapeutic can feel vast.

Join us as we explore how to bridge that gap — building the connections, capabilities, and collaborations that turn academic discoveries into medicines.

Pharmacologists, medicinal chemists, drug discovery scientists, in vitro/in vivo scientists, DMPK experts, trainees, and scientists from industry, academia, contract research organizations, biotech, pharma, research institutes, accelerators/incubators, foundations, and government with an interest in drug discovery are all welcome at this colloquium.

The ADDC 2027 Colloquium will be held at the UCSF Mission Bay Conference Center on the University of California, San Francisco Mission Bay campus — situated in San Francisco's biotech and life sciences corridor.